13F-HR: Intel Corp's Q3 2024 13F Filing Reveals Significant Holdings in Astera Labs and Joby Aviation

Intel Corp's latest 13F filing discloses substantial investments in Astera Labs and Joby Aviation as of September 30, 2024.

Summary

• Intel Corp filed its Form 13F for the quarter ended September 30, 2024.
• The filing reveals Intel's holdings as of that date.
• Intel's holdings include Astera Labs, Inc. Common stock valued at $134,835,252, representing 2,573,683 shares.
• The filing also shows Intel's investment in Joby Aviation Inc. Common stock, with a total value of $116,725,048.
• This investment in Joby Aviation is split into two holdings: $102,452,956 representing 20,368,381 shares and $14,272,092 representing 2,837,394 shares.
• Intel also holds Senti Biosciences Inc Common stock valued at $108,588, representing 48,048 shares.
• The total value of the reported holdings is $251,668,888.

Sentiment

Score: 6

Explanation: The document is a standard regulatory filing, so the sentiment is neutral. The investments themselves could be viewed positively, but the document itself is simply a disclosure.

Positives

• The filing provides transparency into Intel's investment portfolio.
• The significant investments in Astera Labs and Joby Aviation suggest confidence in these companies' future prospects.

Industry Context

13F filings are a standard requirement for institutional investment managers with over $100 million in assets under management, providing insights into their investment strategies and portfolio composition. Intel's investments in Astera Labs and Joby Aviation reflect potential strategic interests in the technology and aerospace sectors, respectively.

Stakeholder Impact

• Shareholders can use this information to understand Intel's investment strategy.
• The companies in which Intel invests (Astera Labs, Joby Aviation, and Senti Biosciences) may see impacts on their stock prices based on this disclosure.

Key Dates